The client was developing a Diabetes Management Application and required patent risk assessment in the US and EP jurisdictions. The technology involved diabetes sensors/insulin pens, data processing, advanced metrics, real-time feedback, ISF data integration, and correction-dose adjustment.
Due to a crowded patent landscape, the analysis focused on identifying active patent and pending application claims relevant to the client’s specific product features rather than relying on broad technical similarities.